Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 12:15 pm Sale | 2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Stonepine Capital Management, LLC | 286,395 5.100% | -79,041 (-21.63%) | Filing History |
| 2025-02-10 12:56 pm Purchase | 2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Sio Capital Management LLC | 276,603 5.090% | 276,603 (New Position) | Filing History |
| 2025-02-10 08:36 am Purchase | 2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE | HIRSCHMAN ORIN | 539,300 9.900% | 190,000 (+54.39%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Aprea Therapeutics, Inc. APRE | Nantahala Capital Management, LLC | 411,520 7.300% | 411,520 (New Position) | Filing History |
| 2024-10-10 4:07 pm Purchase | 2024-10-07 | 13G | Aprea Therapeutics, Inc. APRE | Stonepine Capital Management, LLC | 365,436 6.600% | 365,436 (New Position) | Filing History |
| 2024-02-14 08:00 am Purchase | 2023-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Sio Capital Management LLC | 280,000 7.490% | 280,000 (New Position) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | Aprea Therapeutics, Inc. APRE | HIRSCHMAN ORIN | 349,300 11.000% | 4,300 (+1.25%) | Filing History |
| 2023-03-03 06:03 am Purchase | 2023-02-23 | 13G | Aprea Therapeutics, Inc. APRE | HIRSCHMAN ORIN | 345,000 11.000% | 345,000 (New Position) | Filing History |
| 2022-11-15 5:08 pm Unchanged | 2022-10-26 | 13D | Aprea Therapeutics, Inc. APRE | HealthCap VII L.P. | 118,305 4.500% | 0 (Unchanged) | Filing History |
| 2022-06-30 4:34 pm Unchanged | 2022-06-30 | 13D | Aprea Therapeutics, Inc. APRE | HealthCap VII L.P. | 118,305 10.100% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Redmile Group, LLC | 0 0.000% | -63,436 (Position Closed) | Filing History |
| 2022-02-10 8:44 pm Sale | 2021-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Versant Ventures V LLC | 0 0.000% | -58,777 (Position Closed) | Filing History |
| 2021-10-15 4:50 pm Unchanged | 2021-10-13 | 13D | Aprea Therapeutics, Inc. APRE | HealthCap VII L.P. | 118,305 11.200% | 0 (Unchanged) | Filing History |
| 2021-10-12 4:18 pm Sale | 2021-09-30 | 13G | Aprea Therapeutics, Inc. APRE | MORGAN STANLEY MS | 9,248 0.900% | -44,372 (-82.75%) | Filing History |
| 2021-03-24 5:13 pm Purchase | 2021-03-15 | 13G | Aprea Therapeutics, Inc. APRE | MORGAN STANLEY MS | 53,621 5.100% | 53,621 (New Position) | Filing History |
| 2021-02-16 5:08 pm Sale | 2021-02-11 | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 30,958 13.000% | -37,925 (-55.06%) | Filing History |
| 2021-02-16 4:06 pm Sale | 2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Redmile Group, LLC | 63,436 5.990% | -50,000 (-44.08%) | Filing History |
| 2021-02-16 07:32 am Sale | 2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Versant Ventures V LLC | 58,777 5.500% | -67,189 (-53.34%) | Filing History |
| 2021-02-16 06:51 am Sale | 2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE | KDev Investments AB | 89,035 8.400% | -33,207 (-27.17%) | Filing History |
| 2021-02-12 4:17 pm Sale | 2020-12-31 | 13G | La Jolla Pharmaceutical Company LJPC | SECTORAL ASSET MANAGEMENT INC | 163,681 0.770% | -1,306,658 (-88.87%) | Filing History |